CA2184385A1 - Composition for the treatment of lung disease - Google Patents
Composition for the treatment of lung diseaseInfo
- Publication number
- CA2184385A1 CA2184385A1 CA002184385A CA2184385A CA2184385A1 CA 2184385 A1 CA2184385 A1 CA 2184385A1 CA 002184385 A CA002184385 A CA 002184385A CA 2184385 A CA2184385 A CA 2184385A CA 2184385 A1 CA2184385 A1 CA 2184385A1
- Authority
- CA
- Canada
- Prior art keywords
- hydrogen
- 6alkyl
- 3alkyl
- compound
- found
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21242094A | 1994-03-11 | 1994-03-11 | |
US212,420 | 1994-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2184385A1 true CA2184385A1 (en) | 1995-09-14 |
Family
ID=22790936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002184385A Abandoned CA2184385A1 (en) | 1994-03-11 | 1995-03-07 | Composition for the treatment of lung disease |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0755262A4 (de) |
JP (1) | JPH09510212A (de) |
AU (1) | AU686780B2 (de) |
CA (1) | CA2184385A1 (de) |
WO (1) | WO1995024207A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1755661T3 (pl) * | 2004-05-12 | 2014-10-31 | Brigham & Womens Hospital Inc | Gelsolina do stosowania w leczeniu infekcji |
WO2007109056A2 (en) | 2006-03-15 | 2007-09-27 | The Brigham And Women's Hospital, Inc. | Use of gelsolin to diagnose and treat inflammatory diseases |
BR112020024292A2 (pt) | 2018-06-06 | 2021-03-02 | Massachusetts Institute Of Technology | rna circular para translação em células eucarióticas |
AU2020280105A1 (en) | 2019-05-22 | 2022-01-20 | Massachusetts Institute Of Technology | Circular RNA compositions and methods |
CA3160739A1 (en) | 2019-12-04 | 2021-06-10 | Brian Goodman | Circular rna compositions and methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89835A0 (en) * | 1988-04-11 | 1989-12-15 | Merck & Co Inc | Substituted azetidinones,their preparation and pharmaceutical compositions containing them |
DK0526544T3 (da) * | 1990-04-11 | 1999-06-21 | Brigham & Womens Hospital | Terapeutiske anvendelser af actinbindende forbindelser |
IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
US5276139A (en) * | 1991-08-26 | 1994-01-04 | Merck & Co., Inc. | Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones |
-
1995
- 1995-03-07 AU AU20994/95A patent/AU686780B2/en not_active Ceased
- 1995-03-07 WO PCT/US1995/002938 patent/WO1995024207A1/en not_active Application Discontinuation
- 1995-03-07 CA CA002184385A patent/CA2184385A1/en not_active Abandoned
- 1995-03-07 EP EP95913618A patent/EP0755262A4/de not_active Withdrawn
- 1995-03-07 JP JP7523641A patent/JPH09510212A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2099495A (en) | 1995-09-25 |
EP0755262A1 (de) | 1997-01-29 |
EP0755262A4 (de) | 1997-05-07 |
WO1995024207A1 (en) | 1995-09-14 |
AU686780B2 (en) | 1998-02-12 |
JPH09510212A (ja) | 1997-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69727308T2 (de) | HETEROCYCLENDERIVATE DIE FAKTOR Xa HEMMEN | |
AU698705B2 (en) | Thrombin inhibitors | |
AU764334B2 (en) | Dipeptide nitrile Cathepsin K inhibitors | |
KR101321257B1 (ko) | 브라디키닌 길항물질인 신규 벤즈아미드 유도체 | |
LV13338B (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
EP1156045A1 (de) | Amid-derivate und drogen-zusammensetzungen | |
NZ515217A (en) | Aromatic sulfone hydroxamic acid metalloprotease inhibitor | |
DE19620041A1 (de) | Adhäsionsrezeptor-Antagonisten | |
BG105788A (bg) | Сулфамато хидроксамова киселина като металопротеазен инхибитор | |
DE69921994T2 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
JP2001508757A (ja) | フィブリノーゲンレセプターアンタゴニスト | |
EP0796271B1 (de) | Dipeptidische p-amidinobenzylamide mit n-terminalen sulfonyl- bzw. aminosulfonylresten | |
DE10029014A1 (de) | Urokinase-Hemmstoffe | |
WO1999054321A1 (en) | Substituted diamines and their use as cell adhesion inhibitors | |
JP2001521522A (ja) | 新規なハロ−アルコキシカルボニルプロドラッグ | |
CA2184385A1 (en) | Composition for the treatment of lung disease | |
US5747485A (en) | Substituted azetidiones as anti-inflammatory and antidegenerative agents | |
US5591737A (en) | Substituted azetidinones as anti-inflammatory and antidegenerative agents | |
EP2953932B1 (de) | Substituierte carbonsäurederivate als aggrecanase-hemmer zur behandlung von osteoarthritis | |
DE19713000A1 (de) | Adhäsionsrezeptor-Antagonisten | |
WO1999048911A1 (en) | Monobactam enzyme inhibitors | |
EP2132174B1 (de) | Meta-substituierte phenylsulfonylamide sekundärer aminosäureamide als hemmstoffe der matriptase zur hemmung des tumorwachstums und/oder der metastasierung von tumoren | |
ZA200405802B (en) | Heterocyclic compounds having elastase-inhibitory activity and intermediates thereof. | |
US7084134B2 (en) | Thrombin inhibitors | |
JP2002509547A (ja) | フィブリノーゲンレセプターアンタゴニスト |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |